M

Serial Number 98091635
Registration 7733452
700

Registration Progress

Application Filed
Jul 19, 2023
Under Examination
Jul 16, 2024
Approved for Publication
May 21, 2024
Published for Opposition
May 21, 2024
Registered
Mar 18, 2025

Trademark Image

M

Basic Information

Serial Number
98091635
Registration Number
7733452
Filing Date
July 19, 2023
Registration Date
March 18, 2025
Published for Opposition
May 21, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 18, 2025
Registration
Registered
Classes
041

Rights Holder

Marinus Pharmaceuticals, Inc.

03
Address
5 Radnor Corporate Center, Suite 500
100 Matsonford Road
Radnor, PA 19087

Ownership History

Marinus Pharmaceuticals, Inc.

Original Applicant
03
Radnor, PA

Marinus Pharmaceuticals, Inc.

Owner at Publication
03
Radnor, PA

Marinus Pharmaceuticals, Inc.

Original Registrant
03
Radnor, PA

Legal Representation

Attorney
Keith Barritt

USPTO Deadlines

Next Deadline
1955 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-18)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Mar 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 25, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 25, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 20, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 20, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 9, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 9, 2024 IUAF S USE AMENDMENT FILED Loading...
Jul 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 21, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 12, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 12, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 12, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 12, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 12, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 3, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 3, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 3, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 2, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 2, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 2, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 25, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 25, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 25, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 25, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 18, 2023 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 22, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 041
Educational programming series, namely, providing panel discussions, presentation of seminars and non-downloadable webinars, webcasts, and providing online non-downloadable prerecorded videos of panel discussions, seminars, and webinars, all for the caregiver and patient community featuring health information regarding epilepsy disorders, CDKL5 deficiency disorder, and care and treatment resources
First Use Anywhere: Aug 24, 2023
First Use in Commerce: Aug 24, 2023

Additional Information

Design Mark
The mark consists of a stylized letter "m" with the left portion in light purple and the right portion in dark purple, with a yellow dot above the left portion of the "m.".
Color Claim
The color(s) light purple, dark purple, and yellow is/are claimed as a feature of the mark.
Pseudo Mark
MARINUS PHARMACEUTICALS

Classification

International Classes
041